Spago Nanomedical AB (7UX) AI Stock Analysis

Spago Nanomedical AB

(Frankfurt:7UX)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Debt-free balance sheetZero debt reduces fixed financial obligations and lowers refinancing and interest-cost pressure while the company advances its development programs. This provides greater financial flexibility than a leveraged structure, although the benefit is tempered by the continuing need to fund operations.

Negative Factors

Minimal and declining revenueExtremely limited and declining revenue shows that Spago has not yet established meaningful commercial scale. The very small revenue base provides little support for operating expenses, limits internally funded growth, and leaves future value heavily dependent on successful development and commercialization.

Spago Nanomedical AB (7UX) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 2.93M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.9
Beta (1Y): 0.87
Revenue Growth: -97.24%
EPS Growth: 23.21%
Country: Germany
Employees: 6
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Spago Nanomedical AB Business Overview & Revenue Model

Company Description

Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gado...

Spago Nanomedical AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:7UX against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:CANTA	70Outperform	SEK 451.68M	2.35	63.09%	―	―	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:IMMU	43Neutral	SEK 348.89M	-3.07	-18.05%	―	―	15.97%
SE:BIOVIC.B	41Neutral	SEK 103.68M	-1.44	-75.51%	―	56.06%	63.95%
SE:XSPRAY	41Neutral	SEK 559.52M	-3.06	-26.00%	―	―	44.46%
SE:FLUO	40Underperform	SEK 498.65M	-6.94	―	―	―	-23.57%

* Healthcare Sector Average

Performance Comparison

DE:7UX and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:7UX	Spago Nanomedical AB	0.01	0.00	0.00%
SE:BIOVIC.B	Biovica International AB Class B	0.36	-0.13	-27.03%
SE:XSPRAY	Xspray Pharma AB	11.80	-12.41	-51.27%
SE:IMMU	Immunicum AB	5.50	-1.90	-25.68%
SE:CANTA	Cantargia AB	1.60	-1.68	-51.16%
SE:FLUO	FluoGuide A/S	30.50	-11.30	-27.03%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Spago Nanomedical AB AI Stock Analysis